Challenges in Ki-67 assessments in pulmonary large-cell neuroendocrine carcinomas.
Ann E WaltsJames M MirochaAlberto M MarchevskyPublished in: Histopathology (2020)
Our findings caution against a blanket use of 20%, 40% or other Ki-67% cut-points for LCNEC diagnosis or prognostication.